Mode
Text Size
Log in / Sign up

Patient Questions

Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.

Gastroenterology

What are the top institutions studying functional dyspepsia over the last twenty years?

Bibliometric analyses show that research on functional dyspepsia has grown over the last 20 years, with China leading in publication volume and the Mayo Clinic ranking as a top…

Gastroenterology

Does this study show how brain connectivity links to functional dyspepsia?

One study shows that people with functional dyspepsia have different levels of brain connectivity and specific chemical changes in their gut that match their symptom severity.

Gastroenterology

How does single-nucleus RNA sequencing apply to fibrosis research?

Single-nucleus RNA sequencing helps researchers map specific cell types and gene networks that drive fibrosis in the liver and kidneys, revealing how healthy repair fails and how…

Gastroenterology

Does OPDIVO QVANTIG help treat esophageal adenocarcinoma?

OPDIVO QVANTIG is not currently approved for esophageal adenocarcinoma, but the active drug inside it, nivolumab, is proven to help treat this cancer when combined with…

Gastroenterology

Is pathologic complete response a good predictor of survival for esophageal adenocarcinoma?

Yes, for esophageal adenocarcinoma, achieving a pathologic complete response after neoadjuvant therapy is strongly linked to better survival, especially in certain subgroups.

Gastroenterology

Does neoadjuvant chemoradiation improve resection rates for esophageal adenocarcinoma patients?

For esophageal adenocarcinoma, neoadjuvant chemoradiation does not improve overall resection rates but does increase R0 (margin-negative) resection rates compared to chemotherapy…

Gastroenterology

Can single-cell RNA sequencing help understand fibrosis in fatty liver disease?

Single-cell RNA sequencing helps map specific immune cells and communication networks that drive fibrosis in fatty liver disease, revealing new targets for treatment.

Gastroenterology

Are there new immunomodulation strategies to treat liver fibrosis?

Yes, new immunomodulation strategies for liver fibrosis focus on reprogramming macrophages, targeting specific immune subsets, and using metabolic therapies like GLP-1 analogues…

Gastroenterology

Is diarrhea in the last few weeks a predictor of slower reaction times?

Research shows that diarrhea in the last few weeks is linked to slower visual reaction times in young children, likely due to nutrient depletion and immune stress.

Gastroenterology

What are the gut microbiome differences between diarrheal and non-diarrheal samples?

Diarrheal gut samples show lower bacterial diversity and higher levels of harmful bacteria like E. coli, while healthy samples have more beneficial bacteria like Faecalibacterium.

Gastroenterology

Can BRAFV600E mutation testing help diagnose high-suspicion thyroid nodules with non-malignant cytology?

BRAFV600E mutation testing can help identify hidden cancers in thyroid nodules that look dangerous on ultrasound but test benign on standard cell samples.

Gastroenterology

Can a comprehensive geriatric assessment help older adults with gastrointestinal malignancies live longer?

Comprehensive geriatric assessment helps older adults with gastrointestinal cancers live longer by identifying frailty and changing treatment plans to avoid complications.

Gastroenterology

Does having Lynch Syndrome mean I will definitely get colon cancer?

Having Lynch Syndrome greatly increases your risk of colon cancer, but it does not mean you will definitely get it. Regular colonoscopies can lower the chance of dying from the…

Gastroenterology

How common is cognitive dysfunction in children who have had a liver transplant?

About 24% of children who have a liver transplant experience cognitive dysfunction, with higher rates in those transplanted before age 1 (39.4%) and in Asia (30.6%).

Gastroenterology

Do people with inflammatory bowel disease have higher risks of kidney stones?

People with inflammatory bowel disease, especially Crohn's disease, have a higher risk of kidney stones due to malabsorption and chronic inflammation.

Gastroenterology

What evidence exists for liver cancer alongside lung, breast, and kidney cancer?

Research shows liver cancer detection using liquid biopsies has high accuracy similar to lung, breast, and kidney cancers, while survival rates for liver cancer have improved…

Gastroenterology

What are the findings on chronic pancreatitis risk in the UK Biobank?

UK Biobank data shows metabolic syndrome, sedentary lifestyles, smoking, and alcohol use increase chronic pancreatitis risk, while a Mediterranean diet lowers it.

Gastroenterology

Does activating the aryl hydrocarbon receptor cause liver damage?

Activating the aryl hydrocarbon receptor can cause liver damage or protect it depending on the specific signals and context, acting as a double-edged sword in liver health.

Gastroenterology

Does mitochondrial dysfunction play a role in liver injury?

Yes, mitochondrial dysfunction is a key driver of liver injury, contributing to cell death and disease progression in conditions like fatty liver and alcohol-associated liver…

Gastroenterology

Does having metabolic syndrome increase my risk of chronic pancreatitis?

Yes, having metabolic syndrome significantly increases your risk of developing chronic pancreatitis, with studies showing the risk more than doubles.

Gastroenterology

Does eating ultra-processed food make my nonalcoholic fatty liver disease worse?

Eating ultra-processed foods is linked to obesity and metabolic disease, which are major drivers of nonalcoholic fatty liver disease (NAFLD).

Gastroenterology

What are the current management options for nonalcoholic fatty liver disease?

Current management for nonalcoholic fatty liver disease focuses on lifestyle changes like weight loss and exercise, while new drug options are being studied but none are yet…

Gastroenterology

Does exercise training help reduce liver fat in people with nonalcoholic fatty liver disease?

Yes, exercise training reduces liver fat in people with NAFLD, with high-intensity interval training and aerobic exercise showing the strongest effects.

Gastroenterology

How does exercise training improve metabolic markers for nonalcoholic fatty liver disease?

Exercise training reduces liver fat, lowers blood sugar and insulin, and improves mitochondrial function in people with nonalcoholic fatty liver disease.

How this works

We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.

This is not medical advice. Always speak with your own doctor before making decisions about your health.